Al-Kindi Company for the Production of Veterinary Vaccines and Medicines has submitted its financial statements for the third quarter of 2026 to Iraqi Securities Commission, in compliance with ISX financial disclosure requirements.

Al-Kindi Company for the Production of Veterinary Vaccines and Medicines has submitted its financial statements for the third quarter of 2026 to Iraqi Securities Commission, in compliance with ISX financial disclosure requirements.